Approach to metabolic alkalosis: Clinical sciences

Last updated: January 30, 2025

Approach to metabolic alkalosis: Clinical sciences

Pediatrics

Pediatrics

Approach to acid-base disorders: Clinical sciences
Approach to metabolic acidosis: Clinical sciences
Approach to metabolic alkalosis: Clinical sciences
Approach to respiratory acidosis: Clinical sciences
Approach to respiratory alkalosis: Clinical sciences
Approach to hypernatremia (pediatrics): Clinical sciences
Approach to hypocalcemia (pediatrics): Clinical sciences
Approach to hypoglycemia (pediatrics): Clinical sciences
Approach to hyponatremia (pediatrics): Clinical sciences
Adrenal insufficiency: Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Adnexal torsion: Clinical sciences
Appendicitis: Clinical sciences
Approach to abdominal wall and groin masses: Clinical sciences
Approach to dysmenorrhea: Clinical sciences
Cholecystitis: Clinical sciences
Ectopic pregnancy: Clinical sciences
Henoch-Schonlein purpura: Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Intussusception: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Pelvic inflammatory disease: Clinical sciences
Testicular torsion (pediatrics): Clinical sciences
Urinary tract infection (pediatrics): Clinical sciences
Approach to anemia (destruction and sequestration): Clinical sciences
Approach to anemia (underproduction): Clinical sciences
Approach to anemia in the newborn and infant (destruction and blood loss): Clinical sciences
Approach to anemia in the newborn and infant (underproduction): Clinical sciences
Approach to leukemia: Clinical sciences
Iron deficiency and iron deficiency anemia (pediatrics): Clinical sciences
Sickle cell disease: Clinical sciences
Approach to bleeding disorders (platelet dysfunction): Clinical sciences
Approach to bleeding disorders (thrombocytopenia): Clinical sciences
Immune thrombocytopenia: Clinical sciences
Meningitis (pediatrics): Clinical sciences
Sepsis (pediatrics): Clinical sciences
Celiac disease: Clinical sciences
Asthma: Clinical sciences
Bronchiolitis: Clinical sciences
Congestive heart failure: Clinical sciences
COVID-19: Clinical sciences
Croup and epiglottitis: Clinical sciences
Cystic fibrosis and primary ciliary dyskinesia: Clinical sciences
Influenza: Clinical sciences
Pneumonia (pediatrics): Clinical sciences
Tuberculosis (pulmonary): Clinical sciences
Upper respiratory tract infections: Clinical sciences
Clostridioides difficile infection: Clinical sciences
Approach to a fever (over 2 months): Clinical sciences
Acute rheumatic fever and rheumatic heart disease: Clinical sciences
Osteomyelitis (pediatrics): Clinical sciences
Otitis media and externa (pediatrics): Clinical sciences
Pharyngitis, peritonsillar abscess, and retropharyngeal abscess (pediatrics): Clinical sciences
Septic arthritis and transient synovitis (pediatrics): Clinical sciences
Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical sciences
Tuberculosis (extrapulmonary and latent): Clinical sciences
Approach to bacterial causes of fever and rash (pediatrics): Clinical sciences
Acute group A streptococcal infections and sequelae (pediatrics): Clinical sciences
Approach to congenital infections: Clinical sciences
Juvenile idiopathic arthritis: Clinical sciences
Kawasaki disease: Clinical sciences
Lyme disease: Clinical sciences
Periorbital and orbital cellulitis (pediatrics): Clinical sciences
Toxic shock syndrome: Clinical sciences
Staphylococcal scalded skin syndrome and impetigo: Clinical sciences
Approach to a murmur (pediatrics): Clinical sciences
Approach to congenital heart diseases (acyanotic): Clinical sciences
Approach to congenital heart diseases (cyanotic): Clinical sciences
Hypertrophic cardiomyopathy: Clinical sciences
Approach to hepatic masses: Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Approach to a limp (pediatrics): Clinical sciences
Approach to a suspected bone tumor (pediatrics): Clinical sciences
Developmental dysplasia of the hip: Clinical sciences
Legg-Calve-Perthes disease and slipped capital femoral epiphysis: Clinical sciences
Approach to peripheral lymphadenopathy (pediatrics): Clinical sciences
Approach to a red eye: Clinical sciences
Approach to vomiting (newborn and infant): Clinical sciences
Acetaminophen (Paracetamol) toxicity: Clinical sciences
Approach to recreational substance exposure (pediatrics): Clinical sciences
Diabetes mellitus (pediatrics): Clinical sciences
Large bowel obstruction: Clinical sciences
Pyloric stenosis: Clinical sciences
Small bowel obstruction: Clinical sciences
Approach to a fever (0-60 days): Clinical sciences
Approach to jaundice (newborn and infant): Clinical sciences
Non-accidental trauma and neglect (pediatrics): Clinical sciences
Necrotizing enterocolitis: Clinical sciences
Neonatal respiratory distress syndrome: Clinical sciences
Approach to respiratory distress (newborn): Clinical sciences
Approach to cyanosis (newborn): Clinical sciences
Approach to shock (pediatrics): Clinical sciences
Approach to lower airway obstruction (pediatrics): Clinical sciences
Approach to upper airway obstruction (pediatrics): Clinical sciences
Anaphylaxis: Clinical sciences
Foreign body aspiration and ingestion (pediatrics): Clinical sciences
Approach to a first unprovoked seizure (pediatrics): Clinical sciences
Febrile seizure (pediatrics): Clinical sciences
Approach to bradycardia: Clinical sciences
Approach to tachycardia: Clinical sciences
Brief, resolved, unexplained event (BRUE): Clinical sciences
Approach to hematochezia (pediatrics): Clinical sciences
Burns: Clinical sciences
Neurogenic shock: Clinical sciences
Approach to delayed puberty: Clinical sciences
Approach to feeding and eating disorders: Clinical sciences
Approach to neurodevelopmental disorders: Clinical sciences
Approach to precocious puberty: Clinical sciences
Approach to short stature: Clinical sciences
Autism spectrum disorder: Clinical sciences
Approach to a child with Down syndrome (trisomy 21): Clinical sciences
Dyslipidemia: Clinical sciences
Essential hypertension: Clinical sciences
Developmental milestones (newborn and infant): Clinical sciences
Developmental milestones (toddler): Clinical sciences
Developmental milestones (childhood): Clinical sciences
Approach to a rash in the well newborn and infant: Clinical sciences
Immunizations (pediatrics): Clinical sciences
Well-child visit (adolescent): Clinical sciences
Well-child visit (newborn and infant): Clinical sciences
Well-child visit (toddler and child): Clinical sciences
Well-patient care (GYN): Clinical sciences
Sports physical (pediatrics): Clinical sciences
Antidiuretic hormone
Body fluid compartments
Movement of water between body compartments
Sodium homeostasis
Acid-base disturbances: Pathology review
Diabetes insipidus and SIADH: Pathology review
Electrolyte disturbances: Pathology review
Renal failure: Pathology review
Acyanotic congenital heart defects: Pathology review
Adrenal masses: Pathology review
Bacterial and viral skin infections: Pathology review
Bone tumors: Pathology review
Coagulation disorders: Pathology review
Congenital neurological disorders: Pathology review
Cyanotic congenital heart defects: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Headaches: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Leukemias: Pathology review
Lymphomas: Pathology review
Macrocytic anemia: Pathology review
Microcytic anemia: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Nephritic syndromes: Pathology review
Nephrotic syndromes: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Pediatric brain tumors: Pathology review
Pediatric musculoskeletal disorders: Pathology review
Platelet disorders: Pathology review
Renal and urinary tract masses: Pathology review
Seizures: Pathology review
Viral exanthems of childhood: Pathology review
Adrenal insufficiency: Pathology review
Central nervous system infections: Pathology review
Childhood and early-onset psychological disorders: Pathology review
Congenital gastrointestinal disorders: Pathology review
Diabetes mellitus: Pathology review
Environmental and chemical toxicities: Pathology review
Gastrointestinal bleeding: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Inflammatory bowel disease: Pathology review
Medication overdoses and toxicities: Pathology review
Obstructive lung diseases: Pathology review
Pneumonia: Pathology review
Psychiatric emergencies: Pathology review
Shock: Pathology review
Supraventricular arrhythmias: Pathology review
Traumatic brain injury: Pathology review
Ventricular arrhythmias: Pathology review
Congenital TORCH infections: Pathology review
Jaundice: Pathology review
Respiratory distress syndrome: Pathology review
Autosomal trisomies: Pathology review
Cystic fibrosis: Pathology review
Disorders of sex chromosomes: Pathology review
HIV and AIDS: Pathology review
Miscellaneous genetic disorders: Pathology review
Papulosquamous and inflammatory skin disorders: Pathology review
Anxiety disorders, phobias and stress-related disorders: Pathology Review
Developmental and learning disorders: Pathology review
Eating disorders: Pathology review
Mood disorders: Pathology review
Breastfeeding
Pharmacodynamics: Agonist, partial agonist and antagonist
Pharmacodynamics: Desensitization and tolerance
Pharmacodynamics: Drug-receptor interactions
Pharmacokinetics: Drug absorption and distribution
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug metabolism
Androgens and antiandrogens
Estrogens and antiestrogens
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Antihistamines for allergies
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Fluoroquinolones
DNA synthesis inhibitors: Metronidazole
Miscellaneous protein synthesis inhibitors
Protein synthesis inhibitors: Aminoglycosides
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Glucocorticoids
Azoles
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants

Decision-Making Tree

Questions

USMLE® Step 2 style questions USMLE

0 of 4 complete

Start
A 48-year-old woman presents to the emergency department with cough and shortness of breath for the past two days. The patient has not had any recent respiratory infections, has no past significant medical history, and does not take any medication. The cough is productive of yellow sputum and has worsened over the past two days. Temperature is 38.2 ºC (100.8 ºF), pulse is 96/min, respiratory rate is 18/min, blood pressure is 158/95 mm Hg, and SpO2 is 95% on room air. On physical examination, there are biapical wheezes on pulmonary auscultation, which the patient states are chronic. There is no digital clubbing and no new skin lesions. Chest radiograph shows mild left lingular pneumonia. Serum and urine laboratory studies are shown below. Which of the following is the most probable cause of this patient’s metabolic alkalosis? 

 Laboratory Study     Result    
 Serum Sodium     144 mEq/L    
 Serum Potassium     3.0 mEq/L    
 Serum Bicarbonate     30 mEq/L    
 Blood urea nitrogen     16 mg/dL    
 Serum creatinine     1.0 mg/dL    
 Urine osmolality     400 mOsm/kg     
 Urine chloride     45 mEq/L    

Transcript

Watch video only

Metabolic alkalosis refers to an increase in serum bicarbonate concentration, either due to the loss of hydrogen ions from the body or the gain of bicarbonate itself. This can cause the arterial pH to rise above 7.45, and the serum bicarbonate above 27 milliequivalents per liter. As a reference bicarbonates normally range from 22 to 27 miliequivalents per liter. Common causes include prolonged vomiting, hypovolemia, diuretic use, and hypokalemia.

If a patient presents with a chief concern suggesting metabolic alkalosis, first perform an ABCDE assessment to determine if they are stable or unstable. If your patient is unstable, stabilize their airway, breathing, and circulation; obtain IV access and put them on continuous vital sign monitoring. Also, provide supplemental oxygen, if needed.

Here’s a clinical pearl! Patients with severe metabolic alkalosis, meaning pH over 7.6 sometimes require urgent correction of blood pH with hemodialysis, especially if there is volume overload or renal dysfunction.

Let’s move on to stable patients. After the ABCDE assessment, obtain a focused history and physical examination; and order labs, including an arterial blood gas analysis or ABG, and CMP. The history may reveal vomiting or use of loop or thiazide diuretics. Alkalosis increases the protein binding of ionized calcium, so you might find headaches, lethargy, neuromuscular excitability, delirium, tetany, and seizures. Additionally, alkalemia lowers the threshold for anginal symptoms and arrhythmias. Lastly, if there is hypokalemia, the patient might report weakness.

The physical exam might show signs of dehydration, like dry mucous membranes, and decreased skin turgor. As for the labs, ABG typically shows an arterial pH above 7.45, while CMP reveals elevated serum bicarbonate, often above 27 milliequivalents per liter. If you see these findings in history, physical exams and labs, that’s metabolic alkalosis.

Here’s a clinical pearl! Metabolic alkalosis can sometimes coexist with un acid-base disorders, making it hard to identify. To figure this out, you need to check the partial pressure of carbon dioxide or pCO2 on the ABG. If the pCO2 is above the reference range, it might be due to respiratory compensation, or it could mean that metabolic alkalosis and respiratory acidosis are occurring at the same time.

Keep in mind that in chronic metabolic acidosis, pCO2 should increase by about 5 millimeters of mercury for every 10 milliequivalents per liter increase in bicarbonates. On the other hand, if the pCO2 is below the reference range, metabolic alkalosis might be associated with a coexisting respiratory alkalosis.

Now that you’ve diagnosed metabolic alkalosis, let’s assess for exogenous causes. First up is milk-alkali syndrome. Milk-akali is characterized by hypercalcemia, renal insufficiency, and metabolic alkalosis. Hypercalcemia often results from ingestion of excessive amounts of calcium, either as supplements or calcium-based antacids. If it’s not addressed, hypercalcemia can cause renal insufficiency, where the kidney’s ability to excrete bicarbonate is impaired. Consequently, serum bicarbonate levels increase, leading to metabolic alkalosis.

Patients usually have a history of excessive calcium supplementation, or the use of absorbable antacids, like calcium carbonate or sodium bicarbonate. The CMP often shows elevated serum calcium, BUN, and creatinine levels. If you see these findings, diagnose milk-alkali syndrome.

Next, there’s bicarbonate administration. These patients present with a recent history of large-volume alkaline fluid infusion, such as IV sodium bicarbonate, usually to treat acidosis. In this case, bicarbonate administration is the cause of metabolic alkalosis.

Here’s another clinical pearl! In individuals with normal kidney function, the ingestion or administration of alkali results in only transient metabolic alkalosis. Normally functioning kidneys will quickly increase bicarbonate excretion to restore the pH balance. However, in individuals with kidney dysfunction, the effective elimination of excess bicarbonate is compromised, which leads to sustained alkalosis.

Now for endogenous causes… Alright, if there are no exogenous causes of metabolic alkalosis, consider endogenous causes, and obtain a spot urine chloride test. If the urine chloride is 20 milliequivalents per liter or less, it means there is significant renal chloride reabsorption so your patient has chloride-responsive metabolic alkalosis. This is often found in conditions such as gastric alkalosis, cystic fibrosis, and laxative abuse.

Let’s go over chloride-responsive metabolic alkalosis. Let’s start with gastric alkalosis also known as contraction alkalosis. During vomiting or nasogastric suction, hydrogen chloride is lost in the form of gastric acid, so less acid reaches the duodenum where hydrogen chloride is necessary to counterbalance the pancreatic and duodenal secretions of bicarbonates. With insufficient acid, an excess of bicarbonate gets absorbed into the bloodstream, contributing to metabolic alkalosis.

Patients with gastric alkalosis typically present with a history of vomiting or prolonged nasogastric suction. The physical exam might reveal signs of hypovolemia, such as increased heart rate, decreased blood pressure, and dry mucous membranes. With these findings, diagnose gastric alkalosis.

Next up is cystic fibrosis, in which excessive amounts of sodium chloride and water are lost through sweat, leading to extracellular volume contraction. This activates the renin-angiotensin-aldosterone system, or RAAS, which is followed by a rise in angiotensin II and aldosterone levels. Increased aldosterone levels cause the kidneys to secrete more potassium and hydrogen ions while reabsorbing more bicarbonate, which eventually results in metabolic alkalosis.

The patient typically reports a history of recurrent respiratory infections, poor weight gain, and fatty stool, called steatorrhea. The physical exam usually reveals digital clubbing, and lung crackles or wheezing. With these findings, consider cystic fibrosis. Next, order a sweat chloride test and if it’s elevated, diagnose cystic fibrosis.

Okay, time to talk about laxative abuse. History might reveal the use of laxative medications and possibly an eating disorder like bulimia nervosa. Since some patients might not be comfortable reporting this in their history, during physical exam look for signs of self-induced vomiting, such as tooth decay and abrasions on the dorsum of the hands or fingers. CMP usually reveals decreased serum potassium levels. If you see these findings, think laxative abuse.

Sources

  1. "Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease" J Cyst Fibros (2020)
  2. "New guideline for perioperative management of people with inherited salt-wasting alkaloses" Br J Anaesth (2016)
  3. "Metabolic Alkalosis Pathogenesis, Diagnosis, and Treatment: Core Curriculum 2022" Am J Kidney Dis (2022)
  4. "Metabolic Alkalosis: A Brief Pathophysiologic Review" Clin J Am Soc Nephrol (2020)
  5. "Metabolic alkalosis" J Am Soc Nephrol (2000)
  6. "It is chloride depletion alkalosis, not contraction alkalosis" J Am Soc Nephrol (2012)
  7. "Symposium on acid-base homeostasis. The generation and maintenance of metabolic alkalosis" Kidney Int (1972)
  8. "A paraneoplastic potassium and acid-base disturbance" Cleve Clin J Med (2019)